All-4 One Home Healthcare Services, Inc | |
1629 Salem Rd, Suite 101, Virginia Beach, Virginia 23456 | |
(757) 962-7838 | |
Name | All-4 One Home Healthcare Services, Inc |
---|---|
Location | 1629 Salem Rd, Suite 101, Virginia Beach, Virginia |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 497690 |
Ownership Type | Proprietary |
Service Area Zip Codes | 23320, 23321, 23323, 23324, 23325, 23434, 23451, 23452, 23453, 23454, 23455, 23456, 23457, 23462, 23464, 23502, 23503, 23504, 23505, 23508, 23509, 23510, 23513, 23517, 23518, 23523, 23661, 23701, 23702, 23704, 23707 |
NPI Number | 1598932188 |
Organization Name | ALL-4-ONE HOME HEALTHCARE SERVICES, INC. |
Address | 3061 Brickhouse Ct, Suite 103, Virginia Beach, VA 23452 |
Phone Number | 757-962-7838 |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
NPI Number | 1700164506 |
Organization Name | ALL-4-ONE HOME HEALTHCARE SERVICES, INC. |
Address | 1629 Salem Rd, Suite 101, Virginia Beach, VA 23456 |
Phone Number | 757-962-7838 |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
Quality Rating: |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 79.7 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 93.3 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 93.7 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 74.6 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 72.9 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 61.1 | 96.4 |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 92.2 | 79.6 |
How often patients got better at getting in and out of bed | 78.4 | 81.1 |
How often patients got better at bathing | 86.5 | 82.3 |
How often patients’ breathing improved | 87.9 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 72.7 | 75 |
How often home health patients had to be admitted to the hospital | 22.9 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 16.8 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 51.2 | 94 |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | Not Available |
Health team communicated well with them | Not Available |
Health team discussed medicines, pain, and home safety | Not Available |
How patients rated overall care from agency | Not Available |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
The patient survey data of All-4 One Home Healthcare Services, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 76 | 88 |
Percent of patients who reported that their home health team communicated well with them | 76 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 80 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 56 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 43 | 78 |
News Archive
Scientists have found that mosquitoes are changing their hunting routines in response to host cues. For example, in Africa, mosquitoes now recognize when people emerge from bednets in the morning and have begun hunting more often during the day than at night.
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.
› Verified 1 days ago
Best & Dependable Home Health Care Location: 812 Newtown Road, Virginia Beach, Virginia 23462 Ratings: Phone: (757) 363-7542 | |
Interim Healthcare Location: 516 S Independence Blvd Suite 106, Virginia Beach, Virginia 23452 Ratings: Phone: (757) 466-1401 | |
Kindred At Home Location: 5544 Greenwich Road, Suite 300, Virginia Beach, Virginia 23462 Ratings: Phone: (757) 499-2303 | |
Jewish Family Service Of Tidewater, Inc Location: 5000 Corporate Woods Drive - Suite 400, Virginia Beach, Virginia 23462 Ratings: Phone: (757) 489-3111 | |
Hope In-home Care Llc Location: 4638 Haygood Road, Virginia Beach, Virginia 23455 Ratings: NA Phone: (757) 455-0030 | |
Generations Home Health Llc Location: 6477 College Park Square - Suite 210, Virginia Beach, Virginia 23464 Ratings: Phone: (757) 822-6991 |